Punctal occlusion may reduce reactions without worsening symptoms
Steven Silverstein, MD
Advertisement
Silverstein is a founding partner of Silverstein Eye Centers, in Kansas City, Missouri. He is also an assistant professor of ophthalmology at the University of Missouri Kansas City Medical School, and clinical professor of ophthalmology at Kansas City University of Medicine and Biosciences.
Articles by Steven Silverstein, MD
As dexamethasone adds indications, a study confirms efficacy of punctal occlusion for allergic conjunctivitis.
Taking control of a practice’s future with investment, creative thinking
Advertisement
Latest Updated Articles
Intracanalicular insert linked to reduced hyperemia and itchingPublished: June 17th 2022 | Updated:
Four tips for growing a proactive practicePublished: August 10th 2021 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Advancements in laser refractive surgery
2
Kodiak Sciences releases follow-up, 20-week data from APEX study
3
From then to next: Five decades of transformation in ophthalmology
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5
.png "Optometry Times"){kind=logo}
